CompanyDeals

MobiDrop Raises USD 14.8M in Series A+ to Expand Single-Cell Product Pipeline

CompanyDrug

Luye Pharma’s LY01005 Meets Phase III Trial Goals in Breast Cancer Treatment

CompanyDeals

ZGC Shuimu Medtech Raises RMB 100M in Series A+ Round Led by Yijing Capital

CompanyDeals

Innovita Biological Technology’s IPO Raises USD 131.3M for POCT Expansion

CompanyDrug

Fidia Farmaceutici’s Hyalubrix 60 Shows Promise in Treating Arthropathy at Hainan Hospital

CompanyDeals

Linno Pharmaceuticals Raises USD 14.78M for Blood-Brain Barrier Drug Delivery Tech

CompanyDeals

Frontier Biotech Raises USD 51.4M to Advance COVID-19 Drug FB2001

CompanyDeals

Curatia Medical Raises Tens of Millions in Funding Co-led by Hidea Investment

CompanyDeals

Novaremed AG Licenses NRD.E1 to NeuroFront for Greater China Development

Drug

Ascentage Pharma’s Olverembatinib Receives Health Canada Approval for Phase Ib Study

CompanyDrug

Junshi Biosciences’ Toripalimab Receives EC Orphan Drug Designation for NPC

CompanyDeals

Yifeng Pharmacy Chain to Establish New Company with Tangshan Deshuntang